In response to safety issues surrounding cough syrups in India, the CDSCO mandates strict monitoring of high-risk solvents ...

Explore groundbreaking research on biological aging, discover how cellular functions can be reprogrammed, and learn practical ...

Eli Lilly, known for its blockbuster weight-loss and anti-diabetes drugs, is now focusing on neurosciences, with significant ...

Piramal Pharma reduces reliance on Chinese raw materials to single-digit levels to enhance supply-chain resilience amid geopolitical tensions. Chairperson Nandini Piramal discusses the company's ...

Discover how India is addressing cancer drug affordability with a new pricing strategy that aims to lower costs for patients ...

Despite beating quarterly sales and profit expectations, GSK's stock fell due to concerns over its drug pipeline and weak ...

Eli Lilly has announced that its experimental obesity drug, retatrutide, has outperformed Novo's Ozempic in a Phase 3 trial, ...

The Indian Patent Office has rejected a patent application for the BPaL regimen, a groundbreaking treatment for ...

Gandhinagar: The Gujarat government has ordered two pharmaceutical firms to suspend their production with immediate effect after their cough syrups and other medicines were found "Not of Standard ...

Sandoz, the Swiss generic drugmaker, adjusts its sales growth forecast to 5-6% due to supply constraints, impacting investor ...

ETPharma.com brings latest drug shortage news, views and updates from all top sources for the Indian Pharma industry.

ETPharma.com brings latest pharmaceutical imports news, views and updates from all top sources for the Indian Pharma industry.